Gene · 10153
Papers2,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study. | Int J Mol Sci | 2023 | 36982970 | PubTator, text mining | PubMed |
| Five-Factor Personality Dimensions Mediated the Relationship between Parents' Parenting Style Differences and Mental Health among Medical University Students. | Int J Environ Res Public Health | 2023 | 36981815 | PubTator, text mining | PubMed |
| Polycomb Alterations in Acute Myeloid Leukaemia: From Structure to Function. | Cancers (Basel) | 2023 | 36980579 | PubTator, text mining | PubMed |
| Progress toward Better Treatment of Therapy-Related AML. | Cancers (Basel) | 2023 | 36980546 | PubTator, text mining | PubMed |
| Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors. | Blood Adv | 2023 | 36961350 | PubTator, text mining | PubMed |
| Sensing, signalling, and regulatory mechanism of cold-stress tolerance in plants. | Plant Physiol Biochem | 2023 | 36958153 | PubTator, text mining | PubMed |
| Identifying prognostic gene panels in acute myeloid leukemia. | Expert Rev Hematol | 2023 | 36951195 | PubTator, text mining | PubMed |
| Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience. | Haematologica | 2023 | 36951151 | PubTator, text mining | PubMed |
| Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia. | Front Oncol | 2023 | 36950550 | PubTator, text mining | PubMed |
| Antiviral therapy defiant mixed viral retinitis post hematopoietic allogeneic stem cell transplant. | Clin Case Rep | 2023 | 36937625 | PubTator, text mining | PubMed |
| Numerical and Experimental Investigations of Cold-Sprayed Basalt Fiber-Reinforced Metal Matrix Composite Coating. | Materials (Basel) | 2023 | 36902977 | PubTator, text mining | PubMed |
| Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36902450 | PubTator, text mining | PubMed |
| Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. | Int J Mol Sci | 2023 | 36902217 | PubTator, text mining | PubMed |
| Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse? | Cancers (Basel) | 2023 | 36900222 | PubTator, text mining | PubMed |
| Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review. | Cancers (Basel) | 2023 | 36900154 | PubTator, text mining | PubMed |
| An integrated co-expression network analysis reveals novel genetic biomarkers for immune cell infiltration in chronic kidney disease. | Front Immunol | 2023 | 36875100 | PubTator, text mining | PubMed |
| Therapy-related core binding factor acute myeloid leukemia. | Int J Hematol Oncol | 2023 | 36874378 | PubTator, text mining | PubMed |
| Recent progress and perspectives on physiological and molecular mechanisms underlying cold tolerance of tea plants. | Front Plant Sci | 2023 | 36866358 | PubTator, text mining | PubMed |
| Genetic Diversity of the LTR Region of Polish SRLVs and Its Impact on the Transcriptional Activity of Viral Promoters. | Viruses | 2023 | 36851518 | PubTator, text mining | PubMed |
| Behavioral Intention of Repeated Watching and Personality Traits: Testing Mediation Model of Nostalgia Arousal and Social Connectedness. | Psychol Res Behav Manag | 2023 | 36846312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10153/papers?page=15